Rheinmetalls, Cash

Rheinmetall's Cash Gap Tests the Bull Case After Second Guidance Cut in Three Months

Published on 11/05/2026 at 18:51 | Editorial boerse-global.de
Rheinmetall cut 2026 revenue and margin targets as Arminius Boxer delays and postponed ammunition acceptances shift sales into 2027.
Rheinmetalls, Cash, Gap, Tests, Bull, Case, After, Second, Guidance, Cut Illustration mit AI erstellt.

Rheinmetall shares fell 12% on Wednesday, a day after the defence group trimmed its full-year targets for the second time in three months. The reaction says less about demand for its products than about the market's growing insistence that revenue growth be matched by cash.

The numbers released Wednesday make that tension plain. Sales in the first nine months of 2026 reached EUR 8,376 million, up 38% year on year. Operating profit climbed 68% to EUR 1,339 million, lifting the operating margin to 16.0%. Rheinmetall grew earnings faster than revenue — an improvement that deserves attention even as the guidance cut dominates the headlines.

A quarter that cuts both ways

In the third quarter alone, revenue came in at EUR 3,149 million with an operating result of EUR 553 million and an operating margin of 17.5%. Orders received totalled EUR 2,893 million — below quarterly sales. Operating free cash flow for the period was minus EUR 82 million.

One quarter does not establish a trend. But the combination of soft intake and negative cash generation invites a closer look at how growth converts into liquidity. Over the nine-month stretch, operating free cash flow amounted to minus EUR 1,698 million. Strong operating profit and substantial cash outflow are, for now, running side by side.

Should investors sell immediately? Or is it worth buying Rheinmetall?

Arminius slips, and the year with it

Rheinmetall now expects revenue of around EUR 13.2 billion for 2026, down from a previous range of EUR 13.7 billion to EUR 14.2 billion. The operating margin target was cut to around 18.5% from roughly 19%.

The company blamed likely delays on the Arminius Boxer programme and postponed lot acceptances for artillery ammunition. It no longer expects the Arminius order to land in 2026, and revenue from the delayed ammunition acceptances shifts into 2027. Payments and sales tied to Arminius move into the following year as well. Timing shifts are not the same as lost business — but they matter when judging how dependable a full-year plan is.

Brokers split on what the quarter is worth

JPMorgan's David Perry cut his price target to EUR 1,150 from EUR 1,350 while keeping a "Neutral" rating, pointing to repeated profit warnings and uncertainty around army products and joint ventures, according to dpa-AFX. He had expected a sharp share price decline after the warning and kept his caution on possible negative catalysts.

RBC's Colin Moody took the other side, reaffirming "Outperform" with a EUR 1,600 target. He called the quarterly figures strong, though media reports noted he saw them overshadowed by the clouded annual outlook.

Both readings capture part of the picture. The operating performance argues against a blanket negative verdict; the repeated revisions argue for demanding more from management's forecasts. The more convincing rebuttal to the skeptics would not be another set of strong earnings alone, but evidence that operating strength, on-schedule execution and cash generation are finally moving in the same direction. Rheinmetall's Capital Markets Day on 27 November 2026 now looms as the next real test.

Ad

Rheinmetall Stock: New Analysis - 5 November

Fresh Rheinmetall information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Rheinmetall analysis...

Disclaimer...
en | DE0007030009 | RHEINMETALLS | boerse | 70466015 |